THERESE CASAS: Open Payments
NPI 1588773790 · KINNELON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,566 in 185 payments from 24 companies in 2025. Trend: 2023 $3,368 · 2024 $2,746 · 2025 $4,566
Food & beverage: $3,783Consulting: $500Education: $283
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 2 | $622 |
| Janssen Biotech, Inc. | 10 | $427 |
| Organon LLC | 14 | $415 |
| UCB, Inc. | 14 | $373 |
| ABBVIE INC. | 33 | $343 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 9 | $331 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $232 |
| Lilly USA, LLC | 7 | $222 |
| Galderma Laboratories, L.P. | 21 | $221 |
| GENZYME CORPORATION | 4 | $203 |
Products named: TREMFYA, VTAMA, Bimzelx, SKYRIZI, DUPIXENT, SOFDRA, SILIQ, Zoryve.
Industry payments across NJ — which companies pay providers there.
